Aurobindo Pharma Limited Discontinued
FDA Approved Drugs

Aurobindo Pharma Limited Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 121
  • Latest Approval Date Jun 02, 2026
  • Data Source FDA
  • First Approval Date Jun 30, 1997
All
1128
View
Unclassified
43
View
Discontinued
121
View
OTC
67
View
RX
897
View
Company Overview

Company

Aurobindo Pharma Limited Discontinued

Country

India

Website

Visit Website

Email

info@aurobindo.com

Social Profiles

Company Snapshot

Aurobindo Pharma Limited Discontinued

Plot no. 2, Maitrivihar, Ameerpet, Hyderabad - 500038 Andhra Pradesh

India

www.aurobindo.com/ info@aurobindo.com View on Map
FDA Approved Drug Records ( 121 records )
2017
28 Mar
Discontinued Application: 206151

Drug Name

ABACAVIR SULFATE AND LAMIVUDINE

Product Number

1

Dosage Form

-

Strength

EQ 600MG BASE;300MG

Approval Date

2017-03-28

206151 / 1

Active Ingredient

ABACAVIR SULFATE; LAMIVUDINE

Application Number

206151

Product Number

1

Dosage Form

-

Strength

EQ 600MG BASE;300MG

Approval Date

2017-03-28

Regulatory Status

Discontinued

2020
14 May
Discontinued Application: 213657

Drug Name

ALBUTEROL SULFATE

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2020-05-14

213657 / 1

Active Ingredient

ALBUTEROL SULFATE

Application Number

213657

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2020-05-14

Regulatory Status

Discontinued

2020
14 May
Discontinued Application: 213657

Drug Name

ALBUTEROL SULFATE

Product Number

2

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2020-05-14

213657 / 2

Active Ingredient

ALBUTEROL SULFATE

Application Number

213657

Product Number

2

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2020-05-14

Regulatory Status

Discontinued

2007
17 Jan
Discontinued Application: 65324

Drug Name

AMOXICILLIN

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2007-01-17

65324 / 1

Active Ingredient

AMOXICILLIN

Application Number

65324

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2007-01-17

Regulatory Status

Discontinued

2007
17 Jan
Discontinued Application: 65324

Drug Name

AMOXICILLIN

Product Number

2

Dosage Form

-

Strength

400MG

Approval Date

2007-01-17

65324 / 2

Active Ingredient

AMOXICILLIN

Application Number

65324

Product Number

2

Dosage Form

-

Strength

400MG

Approval Date

2007-01-17

Regulatory Status

Discontinued

2023
26 May
Discontinued Application: 210026

Drug Name

APIXABAN

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2023-05-26

210026 / 1

Active Ingredient

APIXABAN

Application Number

210026

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2023-05-26

Regulatory Status

Discontinued

2023
26 May
Discontinued Application: 210026

Drug Name

APIXABAN

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2023-05-26

210026 / 2

Active Ingredient

APIXABAN

Application Number

210026

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2023-05-26

Regulatory Status

Discontinued

2023
19 Jul
Discontinued Application: 211716

Drug Name

APREMILAST

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2023-07-19

211716 / 1

Active Ingredient

APREMILAST

Application Number

211716

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2023-07-19

Regulatory Status

Discontinued

2023
19 Jul
Discontinued Application: 211716

Drug Name

APREMILAST

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2023-07-19

211716 / 2

Active Ingredient

APREMILAST

Application Number

211716

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2023-07-19

Regulatory Status

Discontinued

2023
19 Jul
Discontinued Application: 211716

Drug Name

APREMILAST

Product Number

3

Dosage Form

-

Strength

30MG

Approval Date

2023-07-19

211716 / 3

Active Ingredient

APREMILAST

Application Number

211716

Product Number

3

Dosage Form

-

Strength

30MG

Approval Date

2023-07-19

Regulatory Status

Discontinued

2020
12 Nov
Discontinued Application: 212775

Drug Name

AZELASTINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

0.2055MG/SPRAY

Approval Date

2020-11-12

212775 / 1

Active Ingredient

AZELASTINE HYDROCHLORIDE

Application Number

212775

Product Number

1

Dosage Form

-

Strength

0.2055MG/SPRAY

Approval Date

2020-11-12

Regulatory Status

Discontinued

2024
22 Jul
Discontinued Application: 217542

Drug Name

BARICITINIB

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2024-07-22

217542 / 1

Active Ingredient

BARICITINIB

Application Number

217542

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2024-07-22

Regulatory Status

Discontinued

2024
22 Jul
Discontinued Application: 217542

Drug Name

BARICITINIB

Product Number

2

Dosage Form

-

Strength

2MG

Approval Date

2024-07-22

217542 / 2

Active Ingredient

BARICITINIB

Application Number

217542

Product Number

2

Dosage Form

-

Strength

2MG

Approval Date

2024-07-22

Regulatory Status

Discontinued

2023
02 Nov
Discontinued Application: 213659

Drug Name

BREXPIPRAZOLE

Product Number

1

Dosage Form

-

Strength

0.25MG

Approval Date

2023-11-02

213659 / 1

Active Ingredient

BREXPIPRAZOLE

Application Number

213659

Product Number

1

Dosage Form

-

Strength

0.25MG

Approval Date

2023-11-02

Regulatory Status

Discontinued

2023
02 Nov
Discontinued Application: 213659

Drug Name

BREXPIPRAZOLE

Product Number

2

Dosage Form

-

Strength

0.5MG

Approval Date

2023-11-02

213659 / 2

Active Ingredient

BREXPIPRAZOLE

Application Number

213659

Product Number

2

Dosage Form

-

Strength

0.5MG

Approval Date

2023-11-02

Regulatory Status

Discontinued

2023
02 Nov
Discontinued Application: 213659

Drug Name

BREXPIPRAZOLE

Product Number

3

Dosage Form

-

Strength

1MG

Approval Date

2023-11-02

213659 / 3

Active Ingredient

BREXPIPRAZOLE

Application Number

213659

Product Number

3

Dosage Form

-

Strength

1MG

Approval Date

2023-11-02

Regulatory Status

Discontinued

2023
02 Nov
Discontinued Application: 213659

Drug Name

BREXPIPRAZOLE

Product Number

4

Dosage Form

-

Strength

2MG

Approval Date

2023-11-02

213659 / 4

Active Ingredient

BREXPIPRAZOLE

Application Number

213659

Product Number

4

Dosage Form

-

Strength

2MG

Approval Date

2023-11-02

Regulatory Status

Discontinued

2023
02 Nov
Discontinued Application: 213659

Drug Name

BREXPIPRAZOLE

Product Number

5

Dosage Form

-

Strength

3MG

Approval Date

2023-11-02

213659 / 5

Active Ingredient

BREXPIPRAZOLE

Application Number

213659

Product Number

5

Dosage Form

-

Strength

3MG

Approval Date

2023-11-02

Regulatory Status

Discontinued

2023
02 Nov
Discontinued Application: 213659

Drug Name

BREXPIPRAZOLE

Product Number

6

Dosage Form

-

Strength

4MG

Approval Date

2023-11-02

213659 / 6

Active Ingredient

BREXPIPRAZOLE

Application Number

213659

Product Number

6

Dosage Form

-

Strength

4MG

Approval Date

2023-11-02

Regulatory Status

Discontinued

2026
20 Apr
Discontinued Application: 210386

Drug Name

CANAGLIFLOZIN

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2026-04-20

210386 / 1

Active Ingredient

CANAGLIFLOZIN

Application Number

210386

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2026-04-20

Regulatory Status

Discontinued

2026
20 Apr
Discontinued Application: 210386

Drug Name

CANAGLIFLOZIN

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2026-04-20

210386 / 2

Active Ingredient

CANAGLIFLOZIN

Application Number

210386

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2026-04-20

Regulatory Status

Discontinued

2025
16 Dec
Discontinued Application: 213982

Drug Name

CARIPRAZINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 1.5MG BASE

Approval Date

2025-12-16

213982 / 1

Active Ingredient

CARIPRAZINE HYDROCHLORIDE

Application Number

213982

Product Number

1

Dosage Form

-

Strength

EQ 1.5MG BASE

Approval Date

2025-12-16

Regulatory Status

Discontinued

2025
16 Dec
Discontinued Application: 213982

Drug Name

CARIPRAZINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 3MG BASE

Approval Date

2025-12-16

213982 / 2

Active Ingredient

CARIPRAZINE HYDROCHLORIDE

Application Number

213982

Product Number

2

Dosage Form

-

Strength

EQ 3MG BASE

Approval Date

2025-12-16

Regulatory Status

Discontinued

2025
16 Dec
Discontinued Application: 213982

Drug Name

CARIPRAZINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 6MG BASE

Approval Date

2025-12-16

213982 / 3

Active Ingredient

CARIPRAZINE HYDROCHLORIDE

Application Number

213982

Product Number

3

Dosage Form

-

Strength

EQ 6MG BASE

Approval Date

2025-12-16

Regulatory Status

Discontinued

2008
08 Aug
Discontinued Application: 65395

Drug Name

CEFAZOLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2008-08-08

65395 / 1

Active Ingredient

CEFAZOLIN SODIUM

Application Number

65395

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2008-08-08

Regulatory Status

Discontinued

2008
08 Aug
Discontinued Application: 65395

Drug Name

CEFAZOLIN SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2008-08-08

65395 / 2

Active Ingredient

CEFAZOLIN SODIUM

Application Number

65395

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2008-08-08

Regulatory Status

Discontinued

2009
06 Nov
Discontinued Application: 65516

Drug Name

CEFOTAXIME SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2009-11-06

65516 / 1

Active Ingredient

CEFOTAXIME SODIUM

Application Number

65516

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2009-11-06

Regulatory Status

Discontinued

2009
06 Nov
Discontinued Application: 65517

Drug Name

CEFOTAXIME SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2009-11-06

65517 / 1

Active Ingredient

CEFOTAXIME SODIUM

Application Number

65517

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2009-11-06

Regulatory Status

Discontinued

2009
06 Nov
Discontinued Application: 65517

Drug Name

CEFOTAXIME SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2009-11-06

65517 / 2

Active Ingredient

CEFOTAXIME SODIUM

Application Number

65517

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2009-11-06

Regulatory Status

Discontinued

2009
06 Nov
Discontinued Application: 65517

Drug Name

CEFOTAXIME SODIUM

Product Number

3

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2009-11-06

65517 / 3

Active Ingredient

CEFOTAXIME SODIUM

Application Number

65517

Product Number

3

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2009-11-06

Regulatory Status

Discontinued

2010
28 May
Discontinued Application: 65481

Drug Name

CEFTAZIDIME

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2010-05-28

65481 / 1

Active Ingredient

CEFTAZIDIME

Application Number

65481

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2010-05-28

Regulatory Status

Discontinued

2010
28 May
Discontinued Application: 65481

Drug Name

CEFTAZIDIME

Product Number

2

Dosage Form

-

Strength

1GM/VIAL

Approval Date

2010-05-28

65481 / 2

Active Ingredient

CEFTAZIDIME

Application Number

65481

Product Number

2

Dosage Form

-

Strength

1GM/VIAL

Approval Date

2010-05-28

Regulatory Status

Discontinued

2010
28 May
Discontinued Application: 65481

Drug Name

CEFTAZIDIME

Product Number

3

Dosage Form

-

Strength

2GM/VIAL

Approval Date

2010-05-28

65481 / 3

Active Ingredient

CEFTAZIDIME

Application Number

65481

Product Number

3

Dosage Form

-

Strength

2GM/VIAL

Approval Date

2010-05-28

Regulatory Status

Discontinued

2010
28 May
Discontinued Application: 65482

Drug Name

CEFTAZIDIME

Product Number

1

Dosage Form

-

Strength

6GM/VIAL

Approval Date

2010-05-28

65482 / 1

Active Ingredient

CEFTAZIDIME

Application Number

65482

Product Number

1

Dosage Form

-

Strength

6GM/VIAL

Approval Date

2010-05-28

Regulatory Status

Discontinued

2008
31 Jul
Discontinued Application: 65504

Drug Name

CEFTRIAXONE

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2008-07-31

65504 / 1

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65504

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2008-07-31

Regulatory Status

Discontinued

2008
31 Jul
Discontinued Application: 65505

Drug Name

CEFTRIAXONE

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/VIAL

Approval Date

2008-07-31

65505 / 1

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65505

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/VIAL

Approval Date

2008-07-31

Regulatory Status

Discontinued

2008
31 Jul
Discontinued Application: 65505

Drug Name

CEFTRIAXONE

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2008-07-31

65505 / 2

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65505

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2008-07-31

Regulatory Status

Discontinued

2008
31 Jul
Discontinued Application: 65505

Drug Name

CEFTRIAXONE

Product Number

3

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2008-07-31

65505 / 3

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65505

Product Number

3

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2008-07-31

Regulatory Status

Discontinued

2008
31 Jul
Discontinued Application: 65505

Drug Name

CEFTRIAXONE

Product Number

4

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2008-07-31

65505 / 4

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65505

Product Number

4

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2008-07-31

Regulatory Status

Discontinued

2009
16 Dec
Discontinued Application: 90751

Drug Name

CETIRIZINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG/5ML

Approval Date

2009-12-16

90751 / 1

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

90751

Product Number

1

Dosage Form

-

Strength

5MG/5ML

Approval Date

2009-12-16

Regulatory Status

Discontinued

2023
08 Mar
Discontinued Application: 212409

Drug Name

CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG;120MG

Approval Date

2023-03-08

212409 / 1

Active Ingredient

CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Application Number

212409

Product Number

1

Dosage Form

-

Strength

5MG;120MG

Approval Date

2023-03-08

Regulatory Status

Discontinued

2024
26 Dec
Discontinued Application: 215971

Drug Name

DEUTETRABENAZINE

Product Number

1

Dosage Form

-

Strength

6MG

Approval Date

2024-12-26

215971 / 1

Active Ingredient

DEUTETRABENAZINE

Application Number

215971

Product Number

1

Dosage Form

-

Strength

6MG

Approval Date

2024-12-26

Regulatory Status

Discontinued

2024
26 Dec
Discontinued Application: 215971

Drug Name

DEUTETRABENAZINE

Product Number

2

Dosage Form

-

Strength

9MG

Approval Date

2024-12-26

215971 / 2

Active Ingredient

DEUTETRABENAZINE

Application Number

215971

Product Number

2

Dosage Form

-

Strength

9MG

Approval Date

2024-12-26

Regulatory Status

Discontinued

2024
26 Dec
Discontinued Application: 215971

Drug Name

DEUTETRABENAZINE

Product Number

3

Dosage Form

-

Strength

12MG

Approval Date

2024-12-26

215971 / 3

Active Ingredient

DEUTETRABENAZINE

Application Number

215971

Product Number

3

Dosage Form

-

Strength

12MG

Approval Date

2024-12-26

Regulatory Status

Discontinued

2012
14 Aug
Discontinued Application: 77275

Drug Name

DIDANOSINE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2012-08-14

77275 / 1

Active Ingredient

DIDANOSINE

Application Number

77275

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2012-08-14

Regulatory Status

Discontinued

2012
14 Aug
Discontinued Application: 77275

Drug Name

DIDANOSINE

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2012-08-14

77275 / 2

Active Ingredient

DIDANOSINE

Application Number

77275

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2012-08-14

Regulatory Status

Discontinued

2012
14 Aug
Discontinued Application: 77275

Drug Name

DIDANOSINE

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2012-08-14

77275 / 3

Active Ingredient

DIDANOSINE

Application Number

77275

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2012-08-14

Regulatory Status

Discontinued

2007
08 Mar
Discontinued Application: 78112

Drug Name

DIDANOSINE

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2007-03-08

78112 / 1

Active Ingredient

DIDANOSINE

Application Number

78112

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2007-03-08

Regulatory Status

Discontinued

2008
24 Sep
Discontinued Application: 90094

Drug Name

DIDANOSINE

Product Number

1

Dosage Form

-

Strength

125MG

Approval Date

2008-09-24

90094 / 1

Active Ingredient

DIDANOSINE

Application Number

90094

Product Number

1

Dosage Form

-

Strength

125MG

Approval Date

2008-09-24

Regulatory Status

Discontinued

2008
24 Sep
Discontinued Application: 90094

Drug Name

DIDANOSINE

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2008-09-24

90094 / 2

Active Ingredient

DIDANOSINE

Application Number

90094

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2008-09-24

Regulatory Status

Discontinued

2008
24 Sep
Discontinued Application: 90094

Drug Name

DIDANOSINE

Product Number

3

Dosage Form

-

Strength

250MG

Approval Date

2008-09-24

90094 / 3

Active Ingredient

DIDANOSINE

Application Number

90094

Product Number

3

Dosage Form

-

Strength

250MG

Approval Date

2008-09-24

Regulatory Status

Discontinued

2008
24 Sep
Discontinued Application: 90094

Drug Name

DIDANOSINE

Product Number

4

Dosage Form

-

Strength

400MG

Approval Date

2008-09-24

90094 / 4

Active Ingredient

DIDANOSINE

Application Number

90094

Product Number

4

Dosage Form

-

Strength

400MG

Approval Date

2008-09-24

Regulatory Status

Discontinued

2018
30 Aug
Discontinued Application: 205322

Drug Name

EFAVIRENZ

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

2018-08-30

205322 / 1

Active Ingredient

EFAVIRENZ

Application Number

205322

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

2018-08-30

Regulatory Status

Discontinued

2018
15 Aug
Discontinued Application: 22343

Drug Name

EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE

Product Number

1

Dosage Form

-

Strength

600MG;300MG;300MG

Approval Date

2018-08-15

22343 / 1

Active Ingredient

EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Application Number

22343

Product Number

1

Dosage Form

-

Strength

600MG;300MG;300MG

Approval Date

2018-08-15

Regulatory Status

Discontinued

2021
29 Mar
Discontinued Application: 212066

Drug Name

EFINACONAZOLE

Product Number

1

Dosage Form

-

Strength

10%

Approval Date

2021-03-29

212066 / 1

Active Ingredient

EFINACONAZOLE

Application Number

212066

Product Number

1

Dosage Form

-

Strength

10%

Approval Date

2021-03-29

Regulatory Status

Discontinued

2026
02 Jun
Discontinued Application: 213511

Drug Name

ELUXADOLINE

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

2026-06-02

213511 / 1

Active Ingredient

ELUXADOLINE

Application Number

213511

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

2026-06-02

Regulatory Status

Discontinued

2026
02 Jun
Discontinued Application: 213511

Drug Name

ELUXADOLINE

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2026-06-02

213511 / 2

Active Ingredient

ELUXADOLINE

Application Number

213511

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2026-06-02

Regulatory Status

Discontinued

2023
13 Jul
Discontinued Application: 216947

Drug Name

ERTUGLIFLOZIN

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2023-07-13

216947 / 1

Active Ingredient

ERTUGLIFLOZIN

Application Number

216947

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2023-07-13

Regulatory Status

Discontinued

2023
13 Jul
Discontinued Application: 216947

Drug Name

ERTUGLIFLOZIN

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2023-07-13

216947 / 2

Active Ingredient

ERTUGLIFLOZIN

Application Number

216947

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2023-07-13

Regulatory Status

Discontinued

2023
30 Jun
Discontinued Application: 214729

Drug Name

ETYQA

Product Number

1

Dosage Form

-

Strength

0.5MG;0.1MG

Approval Date

2023-06-30

214729 / 1

Active Ingredient

ESTRADIOL; NORETHINDRONE ACETATE

Application Number

214729

Product Number

1

Dosage Form

-

Strength

0.5MG;0.1MG

Approval Date

2023-06-30

Regulatory Status

Discontinued

2023
30 Jun
Discontinued Application: 214729

Drug Name

ETYQA

Product Number

2

Dosage Form

-

Strength

1MG;0.5MG

Approval Date

2023-06-30

214729 / 2

Active Ingredient

ESTRADIOL; NORETHINDRONE ACETATE

Application Number

214729

Product Number

2

Dosage Form

-

Strength

1MG;0.5MG

Approval Date

2023-06-30

Regulatory Status

Discontinued

2007
18 Oct
Discontinued Application: 77537

Drug Name

GLYBURIDE

Product Number

1

Dosage Form

-

Strength

1.25MG

Approval Date

2007-10-18

77537 / 1

Active Ingredient

GLYBURIDE

Application Number

77537

Product Number

1

Dosage Form

-

Strength

1.25MG

Approval Date

2007-10-18

Regulatory Status

Discontinued

2007
18 Oct
Discontinued Application: 77537

Drug Name

GLYBURIDE

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2007-10-18

77537 / 2

Active Ingredient

GLYBURIDE

Application Number

77537

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2007-10-18

Regulatory Status

Discontinued

2007
18 Oct
Discontinued Application: 77537

Drug Name

GLYBURIDE

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2007-10-18

77537 / 3

Active Ingredient

GLYBURIDE

Application Number

77537

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2007-10-18

Regulatory Status

Discontinued

2025
30 Jun
Discontinued Application: 219538

Drug Name

IBUPROFEN AND FAMOTIDINE

Product Number

1

Dosage Form

-

Strength

26.6MG;800MG

Approval Date

2025-06-30

219538 / 1

Active Ingredient

FAMOTIDINE; IBUPROFEN

Application Number

219538

Product Number

1

Dosage Form

-

Strength

26.6MG;800MG

Approval Date

2025-06-30

Regulatory Status

Discontinued

2016
27 Dec
Discontinued Application: 204243

Drug Name

INDOMETHACIN

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

2016-12-27

204243 / 1

Active Ingredient

INDOMETHACIN

Application Number

204243

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

2016-12-27

Regulatory Status

Discontinued

2011
17 Nov
Discontinued Application: 202032

Drug Name

LAMIVUDINE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2011-11-17

202032 / 1

Active Ingredient

LAMIVUDINE

Application Number

202032

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2011-11-17

Regulatory Status

Discontinued

2011
17 Nov
Discontinued Application: 202032

Drug Name

LAMIVUDINE

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2011-11-17

202032 / 2

Active Ingredient

LAMIVUDINE

Application Number

202032

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2011-11-17

Regulatory Status

Discontinued

2018
15 May
Discontinued Application: 22344

Drug Name

LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE

Product Number

1

Dosage Form

-

Strength

300MG;300MG

Approval Date

2018-05-15

22344 / 1

Active Ingredient

LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Application Number

22344

Product Number

1

Dosage Form

-

Strength

300MG;300MG

Approval Date

2018-05-15

Regulatory Status

Discontinued

2012
15 May
Discontinued Application: 202418

Drug Name

LAMIVUDINE AND ZIDOVUDINE

Product Number

1

Dosage Form

-

Strength

150MG;300MG

Approval Date

2012-05-15

202418 / 1

Active Ingredient

LAMIVUDINE; ZIDOVUDINE

Application Number

202418

Product Number

1

Dosage Form

-

Strength

150MG;300MG

Approval Date

2012-05-15

Regulatory Status

Discontinued

2023
06 Jan
Discontinued Application: 210826

Drug Name

LEVOMILNACIPRAN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2023-01-06

210826 / 1

Active Ingredient

LEVOMILNACIPRAN HYDROCHLORIDE

Application Number

210826

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2023-01-06

Regulatory Status

Discontinued

2023
06 Jan
Discontinued Application: 210826

Drug Name

LEVOMILNACIPRAN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2023-01-06

210826 / 2

Active Ingredient

LEVOMILNACIPRAN HYDROCHLORIDE

Application Number

210826

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2023-01-06

Regulatory Status

Discontinued

2023
06 Jan
Discontinued Application: 210826

Drug Name

LEVOMILNACIPRAN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2023-01-06

210826 / 3

Active Ingredient

LEVOMILNACIPRAN HYDROCHLORIDE

Application Number

210826

Product Number

3

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2023-01-06

Regulatory Status

Discontinued

2023
06 Jan
Discontinued Application: 210826

Drug Name

LEVOMILNACIPRAN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 120MG BASE

Approval Date

2023-01-06

210826 / 4

Active Ingredient

LEVOMILNACIPRAN HYDROCHLORIDE

Application Number

210826

Product Number

4

Dosage Form

-

Strength

EQ 120MG BASE

Approval Date

2023-01-06

Regulatory Status

Discontinued

2024
16 Jul
Discontinued Application: 216414

Drug Name

LEVOTHYROXINE SODIUM

Product Number

1

Dosage Form

-

Strength

0.137MG

Approval Date

2024-07-16

216414 / 1

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

216414

Product Number

1

Dosage Form

-

Strength

0.137MG

Approval Date

2024-07-16

Regulatory Status

Discontinued

2024
16 Jul
Discontinued Application: 216414

Drug Name

LEVOTHYROXINE SODIUM

Product Number

2

Dosage Form

-

Strength

0.15MG

Approval Date

2024-07-16

216414 / 2

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

216414

Product Number

2

Dosage Form

-

Strength

0.15MG

Approval Date

2024-07-16

Regulatory Status

Discontinued

2024
16 Jul
Discontinued Application: 216414

Drug Name

LEVOTHYROXINE SODIUM

Product Number

3

Dosage Form

-

Strength

0.175MG

Approval Date

2024-07-16

216414 / 3

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

216414

Product Number

3

Dosage Form

-

Strength

0.175MG

Approval Date

2024-07-16

Regulatory Status

Discontinued

2024
16 Jul
Discontinued Application: 216414

Drug Name

LEVOTHYROXINE SODIUM

Product Number

4

Dosage Form

-

Strength

0.2MG

Approval Date

2024-07-16

216414 / 4

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

216414

Product Number

4

Dosage Form

-

Strength

0.2MG

Approval Date

2024-07-16

Regulatory Status

Discontinued

2024
16 Jul
Discontinued Application: 216414

Drug Name

LEVOTHYROXINE SODIUM

Product Number

5

Dosage Form

-

Strength

0.3MG

Approval Date

2024-07-16

216414 / 5

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

216414

Product Number

5

Dosage Form

-

Strength

0.3MG

Approval Date

2024-07-16

Regulatory Status

Discontinued

2023
07 Feb
Discontinued Application: 209611

Drug Name

LINACLOTIDE

Product Number

1

Dosage Form

-

Strength

145MCG

Approval Date

2023-02-07

209611 / 1

Active Ingredient

LINACLOTIDE

Application Number

209611

Product Number

1

Dosage Form

-

Strength

145MCG

Approval Date

2023-02-07

Regulatory Status

Discontinued

2023
07 Feb
Discontinued Application: 209611

Drug Name

LINACLOTIDE

Product Number

2

Dosage Form

-

Strength

290MCG

Approval Date

2023-02-07

209611 / 2

Active Ingredient

LINACLOTIDE

Application Number

209611

Product Number

2

Dosage Form

-

Strength

290MCG

Approval Date

2023-02-07

Regulatory Status

Discontinued

2024
22 Nov
Discontinued Application: 217498

Drug Name

MOMETASONE FUROATE

Product Number

1

Dosage Form

-

Strength

0.05MG/SPRAY

Approval Date

2024-11-22

217498 / 1

Active Ingredient

MOMETASONE FUROATE

Application Number

217498

Product Number

1

Dosage Form

-

Strength

0.05MG/SPRAY

Approval Date

2024-11-22

Regulatory Status

Discontinued

2025
03 Oct
Discontinued Application: 216504

Drug Name

NAPROXEN

Product Number

1

Dosage Form

-

Strength

25MG/ML

Approval Date

2025-10-03

216504 / 1

Active Ingredient

NAPROXEN

Application Number

216504

Product Number

1

Dosage Form

-

Strength

25MG/ML

Approval Date

2025-10-03

Regulatory Status

Discontinued

2017
28 Feb
Discontinued Application: 207698

Drug Name

NEVIRAPINE

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

2017-02-28

207698 / 1

Active Ingredient

NEVIRAPINE

Application Number

207698

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

2017-02-28

Regulatory Status

Discontinued

2016
23 Nov
Discontinued Application: 208616

Drug Name

NEVIRAPINE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2016-11-23

208616 / 1

Active Ingredient

NEVIRAPINE

Application Number

208616

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2016-11-23

Regulatory Status

Discontinued

2016
08 Jan
Discontinued Application: 204236

Drug Name

NORETHINDRONE ACETATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2016-01-08

204236 / 1

Active Ingredient

NORETHINDRONE ACETATE

Application Number

204236

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2016-01-08

Regulatory Status

Discontinued

1997
30 Jun
Discontinued Application: 74835

Drug Name

NORTRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

1997-06-30

74835 / 1

Active Ingredient

NORTRIPTYLINE HYDROCHLORIDE

Application Number

74835

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

1997-06-30

Regulatory Status

Discontinued

1997
30 Jun
Discontinued Application: 74835

Drug Name

NORTRIPTYLINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

1997-06-30

74835 / 2

Active Ingredient

NORTRIPTYLINE HYDROCHLORIDE

Application Number

74835

Product Number

2

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

1997-06-30

Regulatory Status

Discontinued

1997
30 Jun
Discontinued Application: 74835

Drug Name

NORTRIPTYLINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

1997-06-30

74835 / 3

Active Ingredient

NORTRIPTYLINE HYDROCHLORIDE

Application Number

74835

Product Number

3

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

1997-06-30

Regulatory Status

Discontinued

1997
30 Jun
Discontinued Application: 74835

Drug Name

NORTRIPTYLINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

1997-06-30

74835 / 4

Active Ingredient

NORTRIPTYLINE HYDROCHLORIDE

Application Number

74835

Product Number

4

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

1997-06-30

Regulatory Status

Discontinued

2023
28 Apr
Discontinued Application: 213201

Drug Name

OMEPRAZOLE MAGNESIUM

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2023-04-28

213201 / 1

Active Ingredient

OMEPRAZOLE MAGNESIUM

Application Number

213201

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2023-04-28

Regulatory Status

Discontinued

2007
31 Jul
Discontinued Application: 78539

Drug Name

ONDANSETRON HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 24MG BASE

Approval Date

2007-07-31

78539 / 3

Active Ingredient

ONDANSETRON HYDROCHLORIDE

Application Number

78539

Product Number

3

Dosage Form

-

Strength

EQ 24MG BASE

Approval Date

2007-07-31

Regulatory Status

Discontinued

2023
06 Dec
Discontinued Application: 216558

Drug Name

OSHIH

Product Number

1

Dosage Form

-

Strength

0.02MG;1MG

Approval Date

2023-12-06

216558 / 1

Active Ingredient

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Application Number

216558

Product Number

1

Dosage Form

-

Strength

0.02MG;1MG

Approval Date

2023-12-06

Regulatory Status

Discontinued

2025
30 Apr
Discontinued Application: 219241

Drug Name

OXCARBAZEPINE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2025-04-30

219241 / 1

Active Ingredient

OXCARBAZEPINE

Application Number

219241

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2025-04-30

Regulatory Status

Discontinued

2025
30 Apr
Discontinued Application: 219241

Drug Name

OXCARBAZEPINE

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2025-04-30

219241 / 2

Active Ingredient

OXCARBAZEPINE

Application Number

219241

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2025-04-30

Regulatory Status

Discontinued

2025
30 Apr
Discontinued Application: 219241

Drug Name

OXCARBAZEPINE

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

2025-04-30

219241 / 3

Active Ingredient

OXCARBAZEPINE

Application Number

219241

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

2025-04-30

Regulatory Status

Discontinued

2021
31 Mar
Discontinued Application: 214728

Drug Name

POTASSIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

10MEQ

Approval Date

2021-03-31

214728 / 1

Active Ingredient

POTASSIUM CHLORIDE

Application Number

214728

Product Number

1

Dosage Form

-

Strength

10MEQ

Approval Date

2021-03-31

Regulatory Status

Discontinued

2021
31 Mar
Discontinued Application: 214728

Drug Name

POTASSIUM CHLORIDE

Product Number

2

Dosage Form

-

Strength

15MEQ

Approval Date

2021-03-31

214728 / 2

Active Ingredient

POTASSIUM CHLORIDE

Application Number

214728

Product Number

2

Dosage Form

-

Strength

15MEQ

Approval Date

2021-03-31

Regulatory Status

Discontinued

2021
31 Mar
Discontinued Application: 214728

Drug Name

POTASSIUM CHLORIDE

Product Number

3

Dosage Form

-

Strength

20MEQ

Approval Date

2021-03-31

214728 / 3

Active Ingredient

POTASSIUM CHLORIDE

Application Number

214728

Product Number

3

Dosage Form

-

Strength

20MEQ

Approval Date

2021-03-31

Regulatory Status

Discontinued

2010
28 Jul
Discontinued Application: 90623

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 15MG BASE/ML

Approval Date

2010-07-28

90623 / 1

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

90623

Product Number

1

Dosage Form

-

Strength

EQ 15MG BASE/ML

Approval Date

2010-07-28

Regulatory Status

Discontinued

2017
13 Nov
Discontinued Application: 207578

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2017-11-13

207578 / 1

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

207578

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2017-11-13

Regulatory Status

Discontinued

2017
13 Nov
Discontinued Application: 207579

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2017-11-13

207579 / 1

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

207579

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2017-11-13

Regulatory Status

Discontinued

2018
16 Jul
Discontinued Application: 211058

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-07-16

211058 / 1

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

211058

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-07-16

Regulatory Status

Discontinued

2018
16 Jul
Discontinued Application: 211058

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2018-07-16

211058 / 2

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

211058

Product Number

2

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2018-07-16

Regulatory Status

Discontinued

2022
11 Oct
Discontinued Application: 207585

Drug Name

RHUZDAH

Product Number

1

Dosage Form

-

Strength

0.035MG;0.4MG

Approval Date

2022-10-11

207585 / 1

Active Ingredient

ETHINYL ESTRADIOL; NORETHINDRONE

Application Number

207585

Product Number

1

Dosage Form

-

Strength

0.035MG;0.4MG

Approval Date

2022-10-11

Regulatory Status

Discontinued

2023
14 Jun
Discontinued Application: 215902

Drug Name

SAFINAMIDE MESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2023-06-14

215902 / 1

Active Ingredient

SAFINAMIDE MESYLATE

Application Number

215902

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2023-06-14

Regulatory Status

Discontinued

2023
14 Jun
Discontinued Application: 215902

Drug Name

SAFINAMIDE MESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2023-06-14

215902 / 2

Active Ingredient

SAFINAMIDE MESYLATE

Application Number

215902

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2023-06-14

Regulatory Status

Discontinued

2026
06 Mar
Discontinued Application: 218459

Drug Name

SIPONIMOD

Product Number

1

Dosage Form

-

Strength

EQ 0.25MG BASE

Approval Date

2026-03-06

218459 / 1

Active Ingredient

SIPONIMOD

Application Number

218459

Product Number

1

Dosage Form

-

Strength

EQ 0.25MG BASE

Approval Date

2026-03-06

Regulatory Status

Discontinued

2026
06 Mar
Discontinued Application: 218459

Drug Name

SIPONIMOD

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2026-03-06

218459 / 2

Active Ingredient

SIPONIMOD

Application Number

218459

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2026-03-06

Regulatory Status

Discontinued

2026
06 Mar
Discontinued Application: 218459

Drug Name

SIPONIMOD

Product Number

3

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2026-03-06

218459 / 3

Active Ingredient

SIPONIMOD

Application Number

218459

Product Number

3

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2026-03-06

Regulatory Status

Discontinued

2008
29 Dec
Discontinued Application: 77672

Drug Name

STAVUDINE

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2008-12-29

77672 / 1

Active Ingredient

STAVUDINE

Application Number

77672

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2008-12-29

Regulatory Status

Discontinued

2008
29 Dec
Discontinued Application: 77672

Drug Name

STAVUDINE

Product Number

2

Dosage Form

-

Strength

40MG

Approval Date

2008-12-29

77672 / 2

Active Ingredient

STAVUDINE

Application Number

77672

Product Number

2

Dosage Form

-

Strength

40MG

Approval Date

2008-12-29

Regulatory Status

Discontinued

2008
29 Dec
Discontinued Application: 77672

Drug Name

STAVUDINE

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2008-12-29

77672 / 3

Active Ingredient

STAVUDINE

Application Number

77672

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2008-12-29

Regulatory Status

Discontinued

2008
29 Dec
Discontinued Application: 77672

Drug Name

STAVUDINE

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2008-12-29

77672 / 4

Active Ingredient

STAVUDINE

Application Number

77672

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2008-12-29

Regulatory Status

Discontinued

2008
29 Dec
Discontinued Application: 77774

Drug Name

STAVUDINE

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2008-12-29

77774 / 1

Active Ingredient

STAVUDINE

Application Number

77774

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2008-12-29

Regulatory Status

Discontinued

2015
20 Oct
Discontinued Application: 204421

Drug Name

TRAMADOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2015-10-20

204421 / 1

Active Ingredient

TRAMADOL HYDROCHLORIDE

Application Number

204421

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2015-10-20

Regulatory Status

Discontinued

2015
20 Oct
Discontinued Application: 204421

Drug Name

TRAMADOL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2015-10-20

204421 / 2

Active Ingredient

TRAMADOL HYDROCHLORIDE

Application Number

204421

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2015-10-20

Regulatory Status

Discontinued

2015
20 Oct
Discontinued Application: 204421

Drug Name

TRAMADOL HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

2015-10-20

204421 / 3

Active Ingredient

TRAMADOL HYDROCHLORIDE

Application Number

204421

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

2015-10-20

Regulatory Status

Discontinued

2020
18 Mar
Discontinued Application: 211315

Drug Name

TRIAMCINOLONE ACETONIDE

Product Number

1

Dosage Form

-

Strength

0.1%

Approval Date

2020-03-18

211315 / 1

Active Ingredient

TRIAMCINOLONE ACETONIDE

Application Number

211315

Product Number

1

Dosage Form

-

Strength

0.1%

Approval Date

2020-03-18

Regulatory Status

Discontinued

2020
18 Mar
Discontinued Application: 211315

Drug Name

TRIAMCINOLONE ACETONIDE

Product Number

2

Dosage Form

-

Strength

0.5%

Approval Date

2020-03-18

211315 / 2

Active Ingredient

TRIAMCINOLONE ACETONIDE

Application Number

211315

Product Number

2

Dosage Form

-

Strength

0.5%

Approval Date

2020-03-18

Regulatory Status

Discontinued

2009
23 Jul
Discontinued Application: 22294

Drug Name

ZIDOVUDINE

Product Number

1

Dosage Form

-

Strength

60MG

Approval Date

2009-07-23

22294 / 1

Active Ingredient

ZIDOVUDINE

Application Number

22294

Product Number

1

Dosage Form

-

Strength

60MG

Approval Date

2009-07-23

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    81 View
  • EDQM CEP
    208 View
  • KDMF
    0 View
  • Japan DMF
    53 View
  • Eudra GMP
    0 View
  • NDC Database
    869 View
  • FDA Approved Drugs Database
    1,128 View
Drug Status Breakdown
121 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ABACAVIR SULFATE AND LAMIVUDINE

Application Number

206151

Product Number

1

Active Ingredient

ABACAVIR SULFATE; LAMIVUDINE

Dosage Form

-

Strength

EQ 600MG BASE;300MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit